Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Arcus Biosciences (RCUS) over the last 9 years, with Q1 2025 value amounting to $1.0 million.

  • Arcus Biosciences' Capital Expenditures fell 7500.0% to $1.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 8181.82%. This contributed to the annual value of $6.0 million for FY2024, which is 7500.0% down from last year.
  • As of Q1 2025, Arcus Biosciences' Capital Expenditures stood at $1.0 million, which was down 7500.0% from $1.0 million recorded in Q4 2024.
  • Arcus Biosciences' Capital Expenditures' 5-year high stood at $10.0 million during Q3 2023, with a 5-year trough of $1.0 million in Q2 2022.
  • Over the past 5 years, Arcus Biosciences' median Capital Expenditures value was $4.0 million (recorded in 2023), while the average stood at $4.2 million.
  • As far as peak fluctuations go, Arcus Biosciences' Capital Expenditures soared by 227226.56% in 2021, and later plummeted by 9000.0% in 2024.
  • Arcus Biosciences' Capital Expenditures (Quarter) stood at $8.4 million in 2021, then tumbled by 76.27% to $2.0 million in 2022, then surged by 200.0% to $6.0 million in 2023, then plummeted by 83.33% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q1 2025, $1.0 million for Q4 2024, and $1.0 million during Q3 2024.